These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11772295)

  • 1. Cardiac protection by pharmacological modulation of inflammation.
    Latini R; Masson S; Bertini R; Maggioni AP; Ghezzi P; Calvillo L
    Expert Opin Investig Drugs; 2001 Nov; 10(11):1913-24. PubMed ID: 11772295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological role of neutrophils in acute myocardial infarction.
    Carbone F; Nencioni A; Mach F; Vuilleumier N; Montecucco F
    Thromb Haemost; 2013 Sep; 110(3):501-14. PubMed ID: 23740239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L; Uzick M
    Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury.
    Steffens S; Montecucco F; Mach F
    Thromb Haemost; 2009 Aug; 102(2):240-7. PubMed ID: 19652874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
    Bertrand MJ; Tardif JC
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature.
    Diamantis E; Kyriakos G; Quiles-Sanchez LV; Farmaki P; Troupis T
    Curr Cardiol Rev; 2017; 13(3):209-216. PubMed ID: 28462692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease.
    Nidorf SM; Eikelboom JW; Thompson PL
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):45-52. PubMed ID: 24038016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison Meta-Analysis of Randomized Trials.
    Bonsu KO; Reidpath DD; Kadirvelu A
    Cardiovasc Ther; 2015 Dec; 33(6):338-46. PubMed ID: 26280110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.
    Koh KK
    Cardiovasc Res; 2000 Sep; 47(4):648-57. PubMed ID: 10974215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation as a therapeutic target in acute ischemic stroke treatment.
    Tuttolomondo A; Di Sciacca R; Di Raimondo D; Renda C; Pinto A; Licata G
    Curr Top Med Chem; 2009; 9(14):1240-60. PubMed ID: 19849665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.
    van Oostrom AJ; van Wijk J; Cabezas MC
    Drugs; 2004; 64 Suppl 2():19-41. PubMed ID: 15765889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of drugs targeting inflammation for the management of coronary artery disease.
    Duchatelle V; Kritikou EA; Tardif JC
    Can J Cardiol; 2012; 28(6):678-86. PubMed ID: 22926034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation.
    Ajamieh H; Farrell GC; McCuskey RS; Yu J; Chu E; Wong HJ; Lam W; Teoh NC
    Liver Int; 2015 Sep; 35(9):2174-86. PubMed ID: 25786512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual modulation of nitric oxide production in the heart during ischaemia/reperfusion injury and inflammation.
    Darra E; Rungatscher A; Carcereri de Prati A; Podesser BK; Faggian G; Scarabelli T; Mazzucco A; Hallström S; Suzuki H
    Thromb Haemost; 2010 Aug; 104(2):200-6. PubMed ID: 20508903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and other agents for vascular inflammation.
    Owens CD
    J Vasc Surg; 2012 Dec; 56(6):1799-806. PubMed ID: 23017371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.